Literature DB >> 17218732

Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome.

Taneli Raivio1, Anne M Wikström, Leo Dunkel.   

Abstract

BACKGROUND: Boys with prepubertal onset of hypogonadotropic hypogonadism (HH) are at a risk of poor testis growth and impaired spermatogenesis. One potential cause for this is deficient proliferation of immature Sertoli cells before and during puberty due to the absence of FSH.
OBJECTIVE: To evaluate the effects of recombinant human FSH (r-hFSH) and human chorionicgonadotropin (hCG) on testicular function and pubertal development in boys with prepubertal onset of HH.
DESIGN: Retrospective clinical study.
SETTING: Two university central hospitals, pediatric referral endocrinology outpatient clinics. PATIENTS: Fourteen boys (aged, 9.9-17.7 years) with prepubertal (testicular volume (TV) <3 ml) onset of HH (idiopathic HH, n=2; Kallman syndrome, n=2; idiopathic panhypopituitarism, n=4; organic panhypopituitarism, n=6). INTERVENTION: Treatment with r-hFSH alone (2 mo-2.8 years) prior to induction of puberty with the combination of FSH and hCG. MAIN OUTCOME MEASURES: Progression of puberty, change in serum inhibin B, spermatogenesis.
RESULTS: r-hFSH alone increased testicular volume twofold, from 0.9+/-0.6 ml (mean+/-s.d.) to 1.8 +/- 1.1 ml (P<0.005), and serum inhibin B threefold, from 27+/-14 to 80+/-57 pg/ml (P<0.01). Three boys with an apparent absence of postnatal hypothalamic-pituitary-testicular axis activation displayed attenuated inhibin B responses to long-term (>or=1 year) r-hFSH (P<0.01). Further significant increase in both TVand inhibin B occurred with induction of puberty with FSH and hCG (P<0.001). Seven boys provided semen samples: one had azoospermia, and others displayed a maximal sperm count range from 2.9 to 92 million/ml (median 8.5 million/ml).
CONCLUSIONS: (i) r-hFSH induces prepubertal testis growth and increases circulating inhibin B levels, findings suggesting proliferation of immature Sertoli cells. (ii) Puberty was successfully induced with hCG and r-hFSH following r-hFSH priming. (iii) Inhibin B appears useful for monitoring spermatogenetic activity in boys treated with hCG. (iv) Despite the extremely small initial testis volume, six out of seven patients (86%) primed with r-hFSH displayed sperm in the ejaculate suggesting beneficial effect of r-hFSH priming on testicular function later in life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218732     DOI: 10.1530/eje.1.02315

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  23 in total

Review 1.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

Review 2.  Pharmacogenetics of follicle-stimulating hormone action.

Authors:  Maris Laan; Marina Grigorova; Ilpo T Huhtaniemi
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

Review 3.  Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment.

Authors:  Ulrich Boehm; Pierre-Marc Bouloux; Mehul T Dattani; Nicolas de Roux; Catherine Dodé; Leo Dunkel; Andrew A Dwyer; Paolo Giacobini; Jean-Pierre Hardelin; Anders Juul; Mohamad Maghnie; Nelly Pitteloud; Vincent Prevot; Taneli Raivio; Manuel Tena-Sempere; Richard Quinton; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2015-07-21       Impact factor: 43.330

Review 4.  Testosterone therapy in children and adolescents: to whom, how, when?

Authors:  Maria Camila Suarez A; Joseph M Israeli; Eliyahu Kresch; Leon Telis; Daniel E Nassau
Journal:  Int J Impot Res       Date:  2022-01-07       Impact factor: 2.896

5.  Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.

Authors:  A Nordenström; S F Ahmed; E van den Akker; J Blair; M Bonomi; C Brachet; L H A Broersen; H L Claahsen-van der Grinten; A B Dessens; A Gawlik; C H Gravholt; A Juul; C Krausz; T Raivio; A Smyth; P Touraine; D Vitali; O M Dekkers
Journal:  Eur J Endocrinol       Date:  2022-04-21       Impact factor: 6.558

6.  Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism.

Authors:  Andrew A Dwyer; Gerasimos P Sykiotis; Frances J Hayes; Paul A Boepple; Hang Lee; Kevin R Loughlin; Martin Dym; Patrick M Sluss; William F Crowley; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2013-09-13       Impact factor: 5.958

7.  Dioxin exposure and age of pubertal onset among Russian boys.

Authors:  Susan A Korrick; Mary M Lee; Paige L Williams; Oleg Sergeyev; Jane S Burns; Donald G Patterson; Wayman E Turner; Larry L Needham; Larisa Altshul; Boris Revich; Russ Hauser
Journal:  Environ Health Perspect       Date:  2011-04-28       Impact factor: 9.031

8.  Prior testosterone replacement therapy may impact spermatogenic response to combined gonadotropin therapy in severe congenital hypogonadotropic hypogonadism.

Authors:  Ravikumar Shah; Virendra Patil; Vijaya Sarathi; Anurag R Lila; Margaret Zacharin; Brijesh Krishnappa; Manjeetkaur Sehemby; Sanjeet Kumar Jaiswal; Pratap L Jadhav; Swati Ramteke-Jadhav; Nalini Shah; Tushar Bandgar
Journal:  Pituitary       Date:  2020-11-23       Impact factor: 4.107

9.  Genetic modification of the association between peripubertal dioxin exposure and pubertal onset in a cohort of Russian boys.

Authors:  Olivier Humblet; Susan A Korrick; Paige L Williams; Oleg Sergeyev; Claude Emond; Linda S Birnbaum; Jane S Burns; Larisa M Altshul; Donald G Patterson; Wayman E Turner; Mary M Lee; Boris Revich; Russ Hauser
Journal:  Environ Health Perspect       Date:  2012-10-10       Impact factor: 9.031

Review 10.  Hypogonadotropic hypogonadism revisited.

Authors:  Renato Fraietta; Daniel Suslik Zylberstejn; Sandro C Esteves
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.